Stephen M. Stribbling

1.4k total citations
25 papers, 1.0k citations indexed

About

Stephen M. Stribbling is a scholar working on Molecular Biology, Biotechnology and Oncology. According to data from OpenAlex, Stephen M. Stribbling has authored 25 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Biotechnology and 7 papers in Oncology. Recurrent topics in Stephen M. Stribbling's work include Cancer Research and Treatments (9 papers), Virus-based gene therapy research (7 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Stephen M. Stribbling is often cited by papers focused on Cancer Research and Treatments (9 papers), Virus-based gene therapy research (7 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Stephen M. Stribbling collaborates with scholars based in United Kingdom, New Zealand and Switzerland. Stephen M. Stribbling's co-authors include Caroline J. Springer, Simon Tazzyman, Nicola J. Brown, Claire E. Lewis, Carolyn A. Staton, Russell Hughes, Anderson J. Ryan, Janet L. Martin, Richard H. J. Beǵent and Robert A. Spooner and has published in prestigious journals such as Nature Biotechnology, Journal of Cell Science and Nature Protocols.

In The Last Decade

Stephen M. Stribbling

25 papers receiving 1.0k citations

Peers

Countries citing papers authored by Stephen M. Stribbling

Since Specialization

Citations

This map shows the geographic impact of Stephen M. Stribbling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen M. Stribbling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen M. Stribbling more than expected).

Fields of papers citing papers by Stephen M. Stribbling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen M. Stribbling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen M. Stribbling. The network helps show where Stephen M. Stribbling may publish in the future.

Co-authorship network of co-authors of Stephen M. Stribbling

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen M. Stribbling. A scholar is included among the top collaborators of Stephen M. Stribbling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen M. Stribbling. Stephen M. Stribbling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Orthotopic and metastatic tumour models in preclinical cancer research 2024 ·Pharmacology & Therapeutics ·Stephen M. Stribbling, (unknown), Anderson J. Ryan	26
2	The cell-line-derived subcutaneous tumor model in preclinical cancer research 2022 ·Nature Protocols ·Stephen M. Stribbling, Anderson J. Ryan	49
3	iRhom2 regulates ERBB signalling to promote KRAS-driven tumour growth of lung cancer cells 2022 ·Journal of Cell Science ·(unknown), Fangfang Lu, Stephen M. Stribbling, Adam G. Grieve, Anderson J. Ryan, Matthew Freeman	10
4	Tracing Nutrient Flux Following Monocarboxylate Transporter-1 Inhibition with AZD3965 2020 ·Cancers ·(unknown), Maciej Kaliszczak, Laurence Carroll, Zachary T. Schug, Kathrin Heinzmann, Nicoleta Baxan, Adrián Benito, Gabriel N. Valbuena, Stephen M. Stribbling, (unknown), Gillian Mackay, Francesco Mauri, John Latigo, Chris Barnes, Hector C. Keun, Eyal Gottlieb, Eric O. Aboagye	15
5	Development of Therapeutic Anti-JAGGED1 Antibodies for Cancer Therapy 2019 ·Molecular Cancer Therapeutics ·Massimo Masiero, Demin Li, Pat Whiteman, (unknown), (unknown), (unknown), Sarah Watts, Stephen M. Stribbling, (unknown), (unknown), Ji‐Liang Li, Chandramouli Chillakuri, Devon Sheppard, Sébastien Serres, Manuel Sarmiento Soto, James Larkin, Nicola R. Sibson, Penny A. Handford, Adrian L. Harris, Alison H. Banham	31
6	Evaluation of apoptosis imaging biomarkers in a genetic model of cell death 2019 ·EJNMMI Research ·Vessela Vassileva, Stephen M. Stribbling, Chris Barnes, Laurence Carroll, (unknown), (unknown), Kathrin Heinzmann, (unknown), Marion MacFarlane, Kathryn Simpson, Caroline Dive, Jamie Honeychurch, Tim Illidge, Eric O. Aboagye	10
7	Depicting Changes in Tumor Biology in Response to Cetuximab Monotherapy or Combination Therapy by Apoptosis and Proliferation Imaging Using ¹⁸F-ICMT-11 and ¹⁸F-FLT PET 2018 ·Journal of Nuclear Medicine ·Kathrin Heinzmann, Quang‐Dé Nguyen, Davina J. Honess, Donna-Michelle Smith, Stephen M. Stribbling, (unknown), Chris Barnes, John R. Griffiths, Eric O. Aboagye	8
8	Immunogenicity and efficacy of the novel cancer vaccine based on simian adenovirus and MVA vectors alone and in combination with PD-1 mAb in a mouse model of prostate cancer 2016 ·Cancer Immunology Immunotherapy ·Federica Cappuccini, Stephen M. Stribbling, Emily Pollock, Adrian V. S. Hill, Irina Redchenko	42
9	Weight loss effects of quaternary salts of 5-amino-1-(chloromethyl)-1,2-dihydro-3H-benz[e]indoles; structure–activity relationships 2011 ·Bioorganic & Medicinal Chemistry ·Moana Tercel, Ralph J. Stevenson, Guo‐Liang Lu, Stephen M. Stribbling, William R. Wilson, (unknown), (unknown), Kathleen G. Mountjoy, William A. Denny	3
10	Nitro-chloromethylbenzindolines: hypoxia-activated prodrugs of potent adenine N 3 DNA minor groove alkylators 2009 ·Molecular Cancer Therapeutics ·William R. Wilson, Stephen M. Stribbling, Frederik B. Pruijn, Sophie P. Syddall, Adam V. Patterson, H.D. Sarath Liyanage, Eileen Smith, (unknown), Moana Tercel	29
11	Identification of key residues involved in mediating the in vivo anti‐tumor/anti‐endothelial activity of Alphastatin 2007 ·Journal of Thrombosis and Haemostasis ·C A Staton, Stephen M. Stribbling, Carlos Garcı́a-Echeverrı́a, Jonathan Bury, Simon Tazzyman, Claire E. Lewis, Nicola J. Brown	12
12	A novel vascular endothelial growth factor-directed therapy that selectively activates cytotoxic prodrugs 2003 ·British Journal of Cancer ·(unknown), Frank Friedlos, (unknown), Stephen M. Stribbling, Jean‐Christian Roussel, Joseph Brueggen, Barbara Stolz, T. O'Reilly, J M Wood, A. Matter, Richard Marais, Caroline J. Springer	11
13	Unsymmetrical DNA Cross-Linking Agents: Combination of the CBI and PBD Pharmacophores 2003 ·Journal of Medicinal Chemistry ·Moana Tercel, Stephen M. Stribbling, Hilary M. Sheppard, Bronwyn G. Siim, Kent K. Wu, Susan M. Pullen, (unknown), William R. Wilson, William A. Denny	54
14	Regressions of Established Breast Carcinoma Xenografts by Carboxypeptidase G2 Suicide Gene Therapy and the Prodrug CMDA Are Due to a Bystander Effect 2000 ·Human Gene Therapy ·Stephen M. Stribbling, Frank Friedlos, Janet L. Martin, Lawrence Davies, Robert A. Spooner, Richard Marais, Caroline J. Springer	42
15	Recent developments in gene-directed enzyme prodrug therapy (GDEPT) for cancer. 1999 ·PubMed ·Ion Niculescu‐Duvaz, (unknown), Stephen M. Stribbling, James Heyes, Judith A. Metcalfe, Caroline J. Springer	17
16	Enhancement of antibody-directed enzyme prodrug therapy in colorectal xenografts by an antivascular agent. 1999 ·PubMed ·RB Pedley, Shreya Sharma, G Boxer, R Boden, Stephen M. Stribbling, Lawrence Davies, Caroline J. Springer, Richard H. J. Beǵent	54
17	The disposition of allyl isothiocyanate in the rat and mouse 1997 ·Food and Chemical Toxicology ·Mary E. Bollard, Stephen M. Stribbling, S. C. Mitchell, John Caldwell	57
18	Biodistribution of an antibody-enzyme conjugate for antibody-directed enzyme prodrug therapy in nude mice bearing a human colon adenocarcinoma xenograft 1997 ·Cancer Chemotherapy and Pharmacology ·Stephen M. Stribbling, Janet L. Martin, RB Pedley, Joan A. Boden, (unknown), Caroline J. Springer	25
19	A cell surface tethered enzyme improves efficiency in gene-directed enzyme prodrug therapy 1997 ·Nature Biotechnology ·Richard Marais, Robert A. Spooner, Stephen M. Stribbling, Yvonne Light, Janet L. Martin, Caroline J. Springer	62
20	The quantitative determination of photofrin and polyhaematoporphyrin in plasma: pitfalls and inaccuracies 1995 ·Journal of Photochemistry and Photobiology B Biology ·David I. Vernon, J. Andrew Holroyd, Stephen M. Stribbling, Stanley B. Brown	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact